title: Immunohistochemical analysis of novel monoclonal antibody PNL2 and comparison with other melanocyte differentiation markers.
abstract: PNL2 is a novel monoclonal antibody, which has recently been introduced as an immunohistochemical reagent to stain melanocyte and tumors derived thereof. In the present study, we analyzed the immunoreactivity of this mAb in various normal tissues, melanocytic nevi, primary and metastatic melanoma, nonmelanocytic tumors, including histologic mimickers of melanoma as well as angiomyolipoma, and multiple cell lines derived from different tumors types. We used several tissue microarray panels as well as selected conventional sections from tissue blocks. For metastatic melanoma, immunoreactivity for PNL2 was compared with A103 (Melan-A/MART-1), T311 (tyrosinase), HMB45 (gp100), and D5 (MITF). Positive staining with PNL2 was found in normal melanocytes and neutrophils, but no other normal cell type. Among melanocytic lesions, both benign nevi as well as primary malignant melanomas, especially epithelioid variants thereof, were commonly immunopositive. Only 1 of 13 desmoplastic melanomas reacted with PNL2. PNL2 showed high sensitivity for metastatic melanoma (87%). In comparison, 82% of metastatic melanomas were positive for A103, 76% for HMB45, 92% for T311, and 84% for D5. The combined use of all five reagents minimized the number of immunonegative cases. None of the selected nonmelanocytic tumors (carcinomas or soft tissue neoplasms) was positive for PNL2 in this series except for angiomyolipomas and chronic myeloid leukemias and 1 single case of a malignant peripheral nerve sheath tumor with heterologous differentiation (malignant Triton tumor). Despite its reactivity with neutrophils, PNL2 appears to be a valuable supplementary reagent for the diagnosis of melanocytic tumors.
authors.affiliation: Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. busamk@mskcc.org
authors.forename: Klaus J
authors.initials: KJ
authors.lastname: Busam
authors.forename: Derya
authors.initials: D
authors.lastname: Kucukgöl
authors.forename: Eiichi
authors.initials: E
authors.lastname: Sato
authors.forename: Denise
authors.initials: D
authors.lastname: Frosina
authors.forename: Julie
authors.initials: J
authors.lastname: Teruya-Feldstein
authors.forename: Achim A
authors.initials: AA
authors.lastname: Jungbluth
mesh_terms: D000911:Antibodies, Monoclonal; D015415:Biomarkers / Q000032:analysis; D002454:Cell Differentiation; D005260:Female; D006801:Humans; D008297:Male; D008544:Melanocytes; D008545:Melanoma / Q000737:chemistry* / Q000556:secondary; D009506:Nevus / Q000737:chemistry* / Q000473:pathology; D012878:Skin Neoplasms / Q000737:chemistry* / Q000473:pathology; D046888:Tissue Array Analysis
chemical_list: D000911:Antibodies, Monoclonal; D015415:Biomarkers